University of Cambridge

University / College


Location: Cambridge, United Kingdom (GB) GB

ISNI: 0000000121885934

ROR: https://ror.org/013meh722

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes (2022) Mavaddat N, Dorling L, Carvalho S, Allen J, Gonzalez-Neira A, Keeman R, Bolla MK, et al. Journal article Consensus statement: Standardized reporting of power-producing luminescent solar concentrator performance (2022) Yang C, Atwater HA, Baldo MA, Baran D, Barile CJ, Barr MC, Bates M, et al. Journal article, Editorial Rare germline copy number variants (CNVs) and breast cancer risk (2022) Dennis J, Tyrer JP, Walker LC, Michailidou K, Dorling L, Bolla MK, Wang Q, et al. Journal article Stabilization of Multimode Schrodinger Cat States Via Normal-Mode Dissipation Engineering (2022) Zapletal P, Nunnenkamp A, Brunelli M Journal article Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study. (2022) Bettiol A, Urban ML, Bello F, Fiori D, Mattioli I, Lopalco G, Iannone F, et al. Journal article Cell line specific alterations in genes associated with dopamine metabolism and signaling in midbrain dopaminergic neurons derived from 22q11.2 deletion carriers with elevated dopamine synthesis capacity (2022) Reid MJ, Rogdaki M, Dutan L, Hanger B, Sabad K, Nagy R, Adhya D, et al. Journal article Clinical Ethics–To Compute, or Not to Compute? (2022) Meier LJ, Hein A, Diepold K, Buyx A Journal article Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes. (2022) Meagher NS, Gorringe KL, Wakefield MJ, Bolithon A, Pang CNI, Chiu DS, Anglesio MS, et al. Journal article Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study (2022) Girard N, Bar J, Garrido P, Garassino MC, McDonald F, Mornex F, Filippi AR, et al. Journal article Differentiability With Respect To The Initial Condition For Hamilton-jacobi Equations (2022) Esteve-Yague C, Zuazua Iriondo E Journal article